ロード中...
Salicylamide Enhances Melanin Synthesis in B16F1 Melanoma Cells
Salicylamide, a non-steroidal anti-inflammatory drug (NSAID), is used as an analgesic and antipyretic agent. We have previously shown that several NSAIDs have anti-melanogenic properties in B16F1 melanoma cells. In contrast, we have found that salicylamide enhances melanin contents in B16F1 melanoma...
保存先:
| 出版年: | Biomol Ther (Seoul) |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Korean Society of Applied Pharmacology
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8255140/ https://ncbi.nlm.nih.gov/pubmed/33731492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4062/biomolther.2020.222 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|